Table 6. Characteristics of deep learning systems for CVD risk predictions (IV).
SN | Studies | SA | PA | V | HA | P TT | MWT | WT | KWT | DOR |
---|---|---|---|---|---|---|---|---|---|---|
1 | Azzorpardi et al. (78) | √ | × | √ | × | × | × | × | × | × |
2 | Biswas et al. (79) | √ | × | √ | × | √ | √ | √ | √ | × |
3 | Biswas et al. (80) | √ | × | √ | × | × | × | × | × | √ |
4 | Biswas et al. (81) | √ | × | √ | × | × | × | × | × | × |
5 | Jain et al. (98) | √ | × | √ | × | × | × | × | × | × |
6 | Jain et al. (99) | √ | × | √ | × | × | × | × | × | × |
7 | Jamthikar et al. (13) | √ | × | √ | × | × | × | × | × | × |
8 | Lakadir et al. (82) | √ | × | √ | × | × | × | × | × | × |
9 | Meshram et al. (83) | √ | × | √ | × | × | × | × | × | × |
10 | Wu et al. (84) | √ | × | √ | × | × | × | × | × | × |
11 | Zhou et al. (85) | √ | × | √ | × | × | × | × | × | × |
12 | Zhou et al. (86) | √ | × | √ | × | × | × | × | × | × |
13 | Ganitidis et al. (87) | √ | × | √ | × | × | × | × | × | × |
14 | Mohannadi et al. (100) | √ | × | √ | × | × | × | × | × | × |
15 | Latha et al. (101) | √ | × | √ | × | × | × | × | × | × |
16 | Otgonbaatar et al. (102) | √ | × | √ | × | × | × | × | × | × |
17 | Jain et al. (103) | √ | × | √ | × | × | × | × | × | × |
18 | Ziegler et al. (88) | √ | × | √ | × | × | × | √ | × | × |
19 | Bortsova et al. (89) | √ | × | √ | √ | × | × | × | × | × |
20 | Zhu et al. (104) | √ | × | √ | × | × | × | × | × | × |
21 | Park et al. (105) | √ | × | √ | × | × | × | × | × | × |
22 | Jain et al. (90) | √ | × | √ | × | × | × | × | × | × |
23 | Savaş et al. (91) | √ | × | × | × | × | × | × | × | × |
24 | Washim et al. (92) | √ | × | √ | × | × | × | × | × | × |
25 | Sudha et al. (93) | √ | × | √ | × | × | × | × | × | × |
26 | Groves et al. (106) | √ | × | √ | × | × | × | × | × | × |
27 | Saba et al. (94) | √ | × | × | × | × | × | × | × | × |
28 | Tsakanikas et al. (107) | √ | × | × | × | × | × | × | × | × |
29 | Koktzoglou et al. (95) | √ | × | × | × | × | × | × | × | × |
30 | Flores et al. (108) | √ | × | × | × | × | × | × | × | × |
31 | Luo et al. (96) | √ | × | × | × | × | × | × | × | × |
32 | Xiao et al. (97) | √ | × | × | × | × | × | × | × | × |
CVD, cardiovascular disease; SN, serial number; SA, statistical analysis; PA, power analysis; V, validation; HA, Hazard analysis; P TT, Paired t-test; MWT, Mann-Whitney test; WT, Wilcoxon test; KWT, Kruskal–Wallis test; DOR, diagnostic odds ratio.